Chapter

Pharmacological aids to smoking cessation

Stuart Rees and Keir E. Lewis

in Smoking Cessation

Published on behalf of Oxford University Press

ISBN: 9780199556250
Published online May 2011 | e-ISBN: 9780199607327 | DOI: http://dx.doi.org/10.1093/med/9780199556250.003.0004

Series: Oxford Respiratory Medicine Library

Pharmacological aids to smoking cessation

More Like This

Show all results sharing this subject:

  • Respiratory Medicine and Pulmonology

GO

Show Summary Details

Preview

• Nicotine replacement therapy approximately doubles the chances of quitting regardless of additional support. • Bupropion and varenicline are effective non-nicotine-based products. • Second-line agents include nortriptyline and clonidine. • Choice of drug is often determined by smokers’ preferences which are affected by previous attempts, side-effect profiles, and potential drug interactions. • Tobacco smoke increases the activity of several liver enzymes, so altered drug pharmacokinetics and pharmacodynamics should be considered when a patient stops smoking.

Chapter.  3979 words. 

Subjects: Respiratory Medicine and Pulmonology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.